Drug intelligence / Profile preview

Jieyoushen

Development stage: Unknown
Modality: Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Gold Nanoparticles → Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems, Stealth (PEGylated) Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Targeted Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Silica Nanoparticles → Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, SLNs → Solid Lipid Nanoparticles → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Nanostructured Lipid Carriers → Solid Lipid Nanoparticles → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Topical

Overview

Jieyoushen (洁悠神) is a long-acting antibacterial material used in China, primarily for the treatment of burn wounds and moist radioactive dermatitis. Clinical observations indicate that when combined with compound Lithospermum oil (复方紫草油), Jieyoushen can effectively shorten wound healing time and hospital stay, reduce infection rates at the wound site, alleviate patient pain, and improve overall clinical outcomes. It has also been applied in the management of moist radiation dermatitis to promote healing[1][2].

Brand names: Jieyoushen
Other names: 洁悠神

Beyond the preview

Go deeper on Jieyoushen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jieyoushen.

Explore the full profile